{"id":"https://openalex.org/W2296751402","doi":"https://doi.org/10.1002/dta.1967","title":"Identification of three cannabimimetic indazole and pyrazole derivatives, APINACA 2H\u2010indazole analogue, AMPPPCA, and 5F\u2010AMPPPCA","display_name":"Identification of three cannabimimetic indazole and pyrazole derivatives, APINACA 2H\u2010indazole analogue, AMPPPCA, and 5F\u2010AMPPPCA","publication_year":2016,"publication_date":"2016-03-09","ids":{"openalex":"https://openalex.org/W2296751402","doi":"https://doi.org/10.1002/dta.1967","mag":"2296751402","pmid":"https://pubmed.ncbi.nlm.nih.gov/26968728"},"language":"en","primary_location":{"id":"doi:10.1002/dta.1967","doi":"https://doi.org/10.1002/dta.1967","is_oa":false,"landing_page_url":"https://doi.org/10.1002/dta.1967","pdf_url":null,"source":{"id":"https://openalex.org/S36361591","display_name":"Drug Testing and Analysis","issn_l":"1942-7603","issn":["1942-7603","1942-7611"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Testing and Analysis","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Wei Jia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1302611135","display_name":"Ministry of Public Security of the People's Republic of China","ror":"https://ror.org/00bt9we26","country_code":"CN","type":"government","lineage":["https://openalex.org/I1302611135"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Wei Jia","raw_affiliation_strings":["National Narcotics Laboratory, Drug Intelligence and Forensic Center of the Ministry of Public Security, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Narcotics Laboratory, Drug Intelligence and Forensic Center of the Ministry of Public Security, Beijing, China","institution_ids":["https://openalex.org/I1302611135"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101543801","display_name":"Xin Meng","orcid":"https://orcid.org/0000-0003-1376-0917","observed_orcids":["https://orcid.org/0000-0003-1376-0917"]},"institutions":[{"id":"https://openalex.org/I1302611135","display_name":"Ministry of Public Security of the People's Republic of China","ror":"https://ror.org/00bt9we26","country_code":"CN","type":"government","lineage":["https://openalex.org/I1302611135"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xin Meng","raw_affiliation_strings":["National Narcotics Laboratory, Drug Intelligence and Forensic Center of the Ministry of Public Security, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Narcotics Laboratory, Drug Intelligence and Forensic Center of the Ministry of Public Security, Beijing, China","institution_ids":["https://openalex.org/I1302611135"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015464151","display_name":"Zhenhua Qian","orcid":"https://orcid.org/0000-0002-4681-2747","observed_orcids":["https://orcid.org/0000-0002-4681-2747"]},"institutions":[{"id":"https://openalex.org/I1302611135","display_name":"Ministry of Public Security of the People's Republic of China","ror":"https://ror.org/00bt9we26","country_code":"CN","type":"government","lineage":["https://openalex.org/I1302611135"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zhenhua Qian","raw_affiliation_strings":["National Narcotics Laboratory, Drug Intelligence and Forensic Center of the Ministry of Public Security, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Narcotics Laboratory, Drug Intelligence and Forensic Center of the Ministry of Public Security, Beijing, China","institution_ids":["https://openalex.org/I1302611135"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112561881","display_name":"Zhendong Hua","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1302611135","display_name":"Ministry of Public Security of the People's Republic of China","ror":"https://ror.org/00bt9we26","country_code":"CN","type":"government","lineage":["https://openalex.org/I1302611135"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zhendong Hua","raw_affiliation_strings":["National Narcotics Laboratory, Drug Intelligence and Forensic Center of the Ministry of Public Security, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Narcotics Laboratory, Drug Intelligence and Forensic Center of the Ministry of Public Security, Beijing, China","institution_ids":["https://openalex.org/I1302611135"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100455265","display_name":"Tao Li","orcid":"https://orcid.org/0000-0001-9835-4744","observed_orcids":["https://orcid.org/0000-0001-9835-4744"]},"institutions":[{"id":"https://openalex.org/I1302611135","display_name":"Ministry of Public Security of the People's Republic of China","ror":"https://ror.org/00bt9we26","country_code":"CN","type":"government","lineage":["https://openalex.org/I1302611135"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Tao Li","raw_affiliation_strings":["National Narcotics Laboratory, Drug Intelligence and Forensic Center of the Ministry of Public Security, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Narcotics Laboratory, Drug Intelligence and Forensic Center of the Ministry of Public Security, Beijing, China","institution_ids":["https://openalex.org/I1302611135"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043710882","display_name":"Cuimei Liu","orcid":"https://orcid.org/0000-0001-9779-3489","observed_orcids":["https://orcid.org/0000-0001-9779-3489"]},"institutions":[{"id":"https://openalex.org/I1302611135","display_name":"Ministry of Public Security of the People's Republic of China","ror":"https://ror.org/00bt9we26","country_code":"CN","type":"government","lineage":["https://openalex.org/I1302611135"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Cuimei Liu","raw_affiliation_strings":["National Narcotics Laboratory, Drug Intelligence and Forensic Center of the Ministry of Public Security, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Narcotics Laboratory, Drug Intelligence and Forensic Center of the Ministry of Public Security, Beijing, China","institution_ids":["https://openalex.org/I1302611135"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5043710882"],"corresponding_institution_ids":["https://openalex.org/I1302611135"],"apc_list":{"value":4440,"currency":"USD","value_usd":4440},"apc_paid":null,"fwci":2.0923,"has_fulltext":false,"cited_by_count":16,"citation_normalized_percentile":{"value":0.83660662,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"9","issue":"2","first_page":"248","last_page":"255"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10414","display_name":"Cannabis and Cannabinoid Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/synthetic-cannabinoids","display_name":"synthetic cannabinoids","score":0.972000002861023},{"id":"https://openalex.org/keywords/indazole-derivatives","display_name":"indazole derivatives","score":0.9129999876022339},{"id":"https://openalex.org/keywords/pyrazoles","display_name":"pyrazole derivatives","score":0.9990000128746033},{"id":"https://openalex.org/keywords/drug-identification","display_name":"drug identification","score":0.5329999923706055},{"id":"https://openalex.org/keywords/structure-elucidation","display_name":"structure elucidation","score":0.5619999766349792},{"id":"https://openalex.org/keywords/cannabis-analogues","display_name":"cannabis analogues","score":0.4020000100135803}],"concepts":[{"id":"https://openalex.org/C2780591553","wikidata":"https://www.wikidata.org/wiki/Q417106","display_name":"Indazole","level":2,"score":0.9724767208099365},{"id":"https://openalex.org/C2777682936","wikidata":"https://www.wikidata.org/wiki/Q408908","display_name":"Pyrazole","level":2,"score":0.8476300239562988},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.804663896560669},{"id":"https://openalex.org/C2778327999","wikidata":"https://www.wikidata.org/wiki/Q188777","display_name":"Carboxamide","level":2,"score":0.6420078277587891},{"id":"https://openalex.org/C162356407","wikidata":"https://www.wikidata.org/wiki/Q180809","display_name":"Mass spectrometry","level":2,"score":0.6382749080657959},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.3905552923679352},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.31641918420791626}],"mesh":[{"descriptor_ui":"D000218","descriptor_name":"Adamantane","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D000218","descriptor_name":"Adamantane","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D002186","descriptor_name":"Cannabinoids","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D002853","descriptor_name":"Chromatography, Liquid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007191","descriptor_name":"Indazoles","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D008401","descriptor_name":"Gas Chromatography-Mass Spectrometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009682","descriptor_name":"Magnetic Resonance Spectroscopy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011619","descriptor_name":"Psychotropic Drugs","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D013058","descriptor_name":"Mass Spectrometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013287","descriptor_name":"Illicit Drugs","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1002/dta.1967","doi":"https://doi.org/10.1002/dta.1967","is_oa":false,"landing_page_url":"https://doi.org/10.1002/dta.1967","pdf_url":null,"source":{"id":"https://openalex.org/S36361591","display_name":"Drug Testing and Analysis","issn_l":"1942-7603","issn":["1942-7603","1942-7611"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Testing and Analysis","raw_type":"journal-article"},{"id":"pmid:26968728","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26968728","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug testing and analysis","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.4043000042438507,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W306038590","https://openalex.org/W603386570","https://openalex.org/W1532405549","https://openalex.org/W1860194048","https://openalex.org/W1909656381","https://openalex.org/W1970083550","https://openalex.org/W1971590308","https://openalex.org/W1976981359","https://openalex.org/W1982523380","https://openalex.org/W1984419768","https://openalex.org/W1990396144","https://openalex.org/W2007661556","https://openalex.org/W2016063557","https://openalex.org/W2022547474","https://openalex.org/W2023918022","https://openalex.org/W2030741576","https://openalex.org/W2036470103","https://openalex.org/W2039016869","https://openalex.org/W2043933291","https://openalex.org/W2060635101","https://openalex.org/W2067830439","https://openalex.org/W2086923941","https://openalex.org/W2098317032","https://openalex.org/W2105155753","https://openalex.org/W2122168089","https://openalex.org/W2173942367","https://openalex.org/W2306386326","https://openalex.org/W4238848118"],"related_works":["https://openalex.org/W2416212597","https://openalex.org/W1982523380","https://openalex.org/W2173942367","https://openalex.org/W1970083550","https://openalex.org/W2568956272","https://openalex.org/W2187682941","https://openalex.org/W4238848118","https://openalex.org/W7097362658","https://openalex.org/W2514589850","https://openalex.org/W1971590308"],"abstract_inverted_index":{"This":[0],"paper":[1],"reports":[2],"analytical":[3,56],"properties":[4,57],"of":[5],"three":[6,18],"cannabimimetic":[7],"indazole":[8],"and":[9,31,49,58],"pyrazole":[10],"derivatives":[11],"seized":[12],"from":[13],"a":[14],"clandestine":[15],"laboratory.":[16],"These":[17,35],"new":[19],"synthetic":[20],"cannabinoids":[21],"include":[22],"N-(1-adamantyl)-2-pentyl-2H-indazole-3-carboxamide":[23],"(APINACA":[24],"2H-indazole":[25],"analogue,":[26],"1),":[27],"N-(1-adamantyl)-4-methyl-1-pentyl-5-phenyl-1H-pyrazole-3-carboxamide":[28],"(AMPPPCA,":[29],"2),":[30],"N-(1-adamantyl)-1-(5-fluoropentyl)-4-methyl-5-phenyl-1H-pyrazole-3-carboxamide":[32],"(5F-AMPPPCA,":[33],"3).":[34],"compounds":[36,62],"were":[37],"identified":[38],"by":[39],"liquid":[40],"chromatography-quadrupole":[41],"time-of-flight-mass":[42],"spectrometry":[43,47],"(LC-QTOF-MS),":[44],"gas":[45],"chromatography-time-of-flight-mass":[46],"(GC-TOF-MS),":[48],"nuclear":[50],"magnetic":[51],"resonance":[52],"(NMR)":[53],"spectroscopy.":[54],"No":[55],"pharmacological":[59],"activities":[60],"about":[61],"1-3":[63],"have":[64],"appeared":[65],"until":[66],"now,":[67],"making":[68],"this":[69],"the":[70],"first":[71],"report":[72],"on":[73],"these":[74],"compounds.":[75],"Copyright":[76],"\u00a9":[77],"2016":[78],"John":[79],"Wiley":[80],"&":[81],"Sons,":[82],"Ltd.":[83]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}